
A total of 11.9 crore shares across six companies, collectively valued at ₹3,652.94 crore, will become eligible for trading on Monday, February 16, following the expiry of their respective shareholder lock-in periods. However, the expiry of a lock-in does not necessarily mean that all these shares will be sold in the open market. This simply means they are now permitted to be traded.
Around 1.36 crore shares, representing 3% of the company’s outstanding equity, will become eligible for trading as its three-month shareholder lock-in concludes on Monday. At current market prices, these shares are valued at approximately ₹754.8 crore. Notably, the stock is trading nearly 40% above its IPO price.
With the end of its six-month and beyond shareholder lock-in period, about 0.2 crore shares worth over ₹24 crore will become eligible for trading starting Monday.
The company will see a significant unlock, with 3.88 crore shares, equivalent to 54% of its outstanding equity, becoming eligible for trade on February 16 as its six-month lock-in ends. At prevailing market prices, these shares are valued at roughly ₹215 crore.
As its three-month shareholder lock-in period concludes, 0.54 crore shares, or 2% of total equity, will become eligible for trading. These shares are currently valued at about ₹114 crore. The stock is presently down around 8% from its IPO price.
A substantial 5.78 crore shares, accounting for 38% of the company’s outstanding equity, will be unlocked on February 16 following the end of its six-month lock-in period. At current levels, these shares carry a market value of approximately ₹2,518 crore.
Also Read: Eli Lilly Reports $1.5 Billion Pre‑Launch Inventory for Weight-Loss Drug Orforglipron
About 0.11 crore shares, or 2% of the company’s outstanding equity, valued at over ₹28.44 crore, will become eligible for trading as its six-month and beyond shareholder lock-in expires on Monday.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 16, 2026, 9:03 AM IST

Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
